{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:56:46Z","timestamp":1777561006593,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune diseases and coronavirus disease 2019 (COVID-19) share many similarities. Concerns have arisen that autoimmune diseases may increase the susceptibility and severity of COVID-19. We used Mendelian randomization to investigate whether liability to autoimmune diseases is related to COVID-19 susceptibility and severity. Genetic instruments for 8 autoimmune diseases, including type 1 diabetes mellitus, rheumatoid arthritis, systemic lupus erythematosus, psoriasis, multiple sclerosis, primary sclerosing cholangitis, primary biliary cirrhosis and juvenile idiopathic arthritis, were obtained from published genome-wide association studies. Two-sample Mendelian randomization analyses of the associations of liability to each autoimmune disease with COVID-19 infection, hospitalized COVID-19, and very severe COVID-19 were performed using the latest publicly available genome-wide association study for COVID-19. Genetic liability to each of the autoimmune diseases was largely not associated with COVID-19 infection, hospitalized COVID-19, or very severe COVID-19 after accounting for multiple comparison. Sensitivity analysis excluding genetic variants in the human leukocyte antigen gene, which has an important role in the immune response, showed similar results. The autoimmune diseases examined were largely not genetically associated with the susceptibility or severity of COVID-19. Further investigations are warranted.<\/jats:p>","DOI":"10.1038\/s41598-022-22711-1","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T19:03:30Z","timestamp":1666379010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19"],"prefix":"10.1038","volume":"12","author":[{"given":"Shun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna C.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"22711_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/bor.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Sawalha, A. H. & Lu, Q. COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 33, 155\u2013162. https:\/\/doi.org\/10.1097\/bor.0000000000000776 (2021).","journal-title":"Curr. Opin. Rheumatol."},{"key":"22711_CR2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1002\/jcp.30076","volume":"236","author":"A Esmaeilzadeh","year":"2021","unstructured":"Esmaeilzadeh, A. & Elahi, R. Immunobiology and immunotherapy of COVID-19: A clinically updated overview. J. Cell Physiol. 236, 2519\u20132543. https:\/\/doi.org\/10.1002\/jcp.30076 (2021).","journal-title":"J. Cell Physiol."},{"key":"22711_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2020.12.007","volume":"232","author":"R Fernandez-Ruiz","year":"2021","unstructured":"Fernandez-Ruiz, R., Paredes, J. L. & Niewold, T. B. COVID-19 in patients with systemic lupus erythematosus: Lessons learned from the inflammatory disease. Transl. Res. 232, 13\u201336. https:\/\/doi.org\/10.1016\/j.trsl.2020.12.007 (2021).","journal-title":"Transl. Res."},{"key":"22711_CR4","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/art.41800","volume":"73","author":"BR England","year":"2021","unstructured":"England, B. R. et al. Risk of COVID-19 in rheumatoid arthritis: A national veterans affairs matched cohort study in at-risk individuals. Arthritis Rheumatol. 73, 2179\u20132188. https:\/\/doi.org\/10.1002\/art.41800 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"22711_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001001","author":"M Barzegar","year":"2021","unstructured":"Barzegar, M. et al. COVID-19 among patients with multiple sclerosis: A systematic review. Neurol. Neuroimmunol. Neuroinflamm. https:\/\/doi.org\/10.1212\/nxi.0000000000001001 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"22711_CR6","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1177\/09612033211045057","volume":"30","author":"R Sakthiswary","year":"2021","unstructured":"Sakthiswary, R., Chuah, H. Y., Chiang, K. S., Liew, Y. S. & Muhammad Aizat, N. A. COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series. Lupus 30, 1946\u20131954. https:\/\/doi.org\/10.1177\/09612033211045057 (2021).","journal-title":"Lupus"},{"key":"22711_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218946","author":"S Akiyama","year":"2020","unstructured":"Akiyama, S., Hamdeh, S., Micic, D. & Sakuraba, A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: A systematic review and meta-analysis. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218946 (2020).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 27","key":"22711_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/pai.13646","volume":"33","author":"G Santacroce","year":"2022","unstructured":"Santacroce, G. et al. Impact of COVID-19 in immunosuppressive drug-na\u00efve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease. Pediatr. Allergy Immunol. 33(Suppl 27), 105\u2013107. https:\/\/doi.org\/10.1111\/pai.13646 (2022).","journal-title":"Pediatr. Allergy Immunol."},{"key":"22711_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003553","volume":"18","author":"A Leong","year":"2021","unstructured":"Leong, A. et al. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis. PLoS Med. 18, e1003553. https:\/\/doi.org\/10.1371\/journal.pmed.1003553 (2021).","journal-title":"PLoS Med."},{"key":"22711_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","volume":"590","author":"M O\u2019Driscoll","year":"2021","unstructured":"O\u2019Driscoll, M. et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 590, 140\u2013145. https:\/\/doi.org\/10.1038\/s41586-020-2918-0 (2021).","journal-title":"Nature"},{"key":"22711_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/rej.2015.1690","volume":"19","author":"LS Lens-Pechakova","year":"2016","unstructured":"Lens-Pechakova, L. S. Centenarian rates and life expectancy related to the death rates of multiple sclerosis, asthma, and rheumatoid arthritis and the incidence of type 1 diabetes in children. Rejuvenation Res. 19, 53\u201358. https:\/\/doi.org\/10.1089\/rej.2015.1690 (2016).","journal-title":"Rejuvenation Res."},{"key":"22711_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.610852","volume":"11","author":"CM Schooling","year":"2020","unstructured":"Schooling, C. M. et al. Use of multivariable mendelian randomization to address biases due to competing risk before recruitment. Front. Genet. 11, 610852. https:\/\/doi.org\/10.3389\/fgene.2020.610852 (2020).","journal-title":"Front. Genet."},{"key":"22711_CR13","doi-asserted-by":"publisher","first-page":"151958","DOI":"10.1016\/j.semarthrit.2022.151958","volume":"53","author":"S Yuan","year":"2022","unstructured":"Yuan, S., Li, X., Lin, A. & Larsson, S. C. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation. Semin. Arthritis Rheum. 53, 151958. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151958 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"22711_CR14","doi-asserted-by":"publisher","first-page":"2003545","DOI":"10.1183\/13993003.03545-2020","volume":"57","author":"SC Larsson","year":"2021","unstructured":"Larsson, S. C., Burgess, S. & Gill, D. Genetically proxied interleukin-6 receptor inhibition: Opposing associations with COVID-19 and pneumonia. Eur. Respir. J. 57, 2003545. https:\/\/doi.org\/10.1183\/13993003.03545-2020 (2021).","journal-title":"Eur. Respir. J."},{"key":"22711_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ueg2.12100","volume":"9","author":"BF Zecher","year":"2021","unstructured":"Zecher, B. F. et al. Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. United Eur. Gastroenterol. J. 9, 797\u2013808. https:\/\/doi.org\/10.1002\/ueg2.12100 (2021).","journal-title":"United Eur. Gastroenterol. J."},{"key":"22711_CR16","first-page":"741","volume":"11","author":"MDP Hernandez","year":"2015","unstructured":"Hernandez, M. D. P., Martin, P. & Simkins, J. Infectious complications after liver transplantation. Gastroenterol. Hepatol. 11, 741\u2013753 (2015).","journal-title":"Gastroenterol. Hepatol."},{"key":"22711_CR17","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.3390\/ijerph17093095","volume":"17","author":"M Carbone","year":"2020","unstructured":"Carbone, M. et al. Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy. Int. J. Environ. Res. Public Health 17, 3095. https:\/\/doi.org\/10.3390\/ijerph17093095 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"22711_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"Ji, S. G. et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat. Genet. 49, 269\u2013273. https:\/\/doi.org\/10.1038\/ng.3745 (2017).","journal-title":"Nat. Genet."},{"key":"22711_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/cts.12908","volume":"14","author":"S Pascolini","year":"2021","unstructured":"Pascolini, S. et al. COVID-19 and immunological dysregulation: Can autoantibodies be useful?. Clin. Transl. Sci. 14, 502\u2013508. https:\/\/doi.org\/10.1111\/cts.12908 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"22711_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","volume":"71","author":"CE Barrett","year":"2022","unstructured":"Barrett, C. E. et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years: United States, March 1, 2020-June 28, 2021. MMWR Morb. Mortal Wkly. Rep. 71, 59\u201365. https:\/\/doi.org\/10.15585\/mmwr.mm7102e2 (2022).","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"22711_CR21","doi-asserted-by":"publisher","first-page":"e8094","DOI":"10.7759\/cureus.8094","volume":"12","author":"F Angum","year":"2020","unstructured":"Angum, F., Khan, T., Kaler, J., Siddiqui, L. & Hussain, A. The prevalence of autoimmune disorders in women: A narrative review. Cureus 12, e8094\u2013e8094. https:\/\/doi.org\/10.7759\/cureus.8094 (2020).","journal-title":"Cureus"},{"key":"22711_CR22","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham, H. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. 11, 6317. https:\/\/doi.org\/10.1038\/s41467-020-19741-6 (2020).","journal-title":"Nat. Commun."},{"key":"22711_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. \u201cMendelian randomization\u201d: Can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 32, 1\u201322 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"22711_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers 2, 6. https:\/\/doi.org\/10.1038\/s43586-021-00092-5 (2022).","journal-title":"Nat. Rev. Methods Primers"},{"key":"22711_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ 362, k601. https:\/\/doi.org\/10.1136\/bmj.k601 (2018).","journal-title":"BMJ"},{"key":"22711_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"S Onengut-Gumuscu","year":"2015","unstructured":"Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381\u2013386. https:\/\/doi.org\/10.1038\/ng.3245 (2015).","journal-title":"Nat. Genet."},{"key":"22711_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381. https:\/\/doi.org\/10.1038\/nature12873 (2014).","journal-title":"Nature"},{"key":"22711_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457\u20131464. https:\/\/doi.org\/10.1038\/ng.3434 (2015).","journal-title":"Nat. Genet."},{"key":"22711_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi, L. C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341\u20131348. https:\/\/doi.org\/10.1038\/ng.2467 (2012).","journal-title":"Nat. Genet."},{"key":"22711_CR30","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1126\/science.aav7188","volume":"365","author":"NA Patsopoulos","year":"2019","unstructured":"Patsopoulos, N. A. et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, 6460. https:\/\/doi.org\/10.1126\/science.aav7188 (2019).","journal-title":"Science"},{"key":"22711_CR31","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ng.2395","volume":"44","author":"JZ Liu","year":"2012","unstructured":"Liu, J. Z. et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 44, 1137\u20131141. https:\/\/doi.org\/10.1038\/ng.2395 (2012).","journal-title":"Nat. Genet."},{"key":"22711_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2020-218481","volume":"80","author":"E L\u00f3pez-Isac","year":"2020","unstructured":"L\u00f3pez-Isac, E. et al. Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms. Ann. Rheum. Dis. 80, 321\u2013328. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218481 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"22711_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41431-020-0636-6","volume":"28","author":"The COVID-19 Host Genetics Initiative","year":"2020","unstructured":"The COVID-19 Host Genetics Initiative. a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur. J. Hum. Genet. 28, 715\u2013718. https:\/\/doi.org\/10.1038\/s41431-020-0636-6 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"22711_CR34","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: The role of the I2 statistic. Int. J. Epidemiol. 45, 1961\u20131974. https:\/\/doi.org\/10.1093\/ije\/dyw220 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"22711_CR35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"key":"22711_CR36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"22711_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965 (2016).","journal-title":"Genet. Epidemiol."},{"key":"22711_CR38","doi-asserted-by":"publisher","first-page":"e0161305","DOI":"10.1371\/journal.pone.0161305","volume":"11","author":"L Ortiz-Fern\u00e1ndez","year":"2016","unstructured":"Ortiz-Fern\u00e1ndez, L. et al. Genetic analysis with the immunochip platform in Beh\u00e7et disease: Identification of residues associated in the HLA class I region and new susceptibility loci. PLoS ONE 11, e0161305. https:\/\/doi.org\/10.1371\/journal.pone.0161305 (2016).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22711-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22711-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22711-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T19:39:05Z","timestamp":1666381145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22711-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22711-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17703"}}